Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Jan 09, 2019 1:15pm

52 Views

Post# 29207120

RE:RE:RE:First Patient Selected

BioTeck wrote: The times are all in the last news release. Safety is expected first half of 2019, big deal, we know it's safe so this won't do anything to the price as it's already been done. Efficacy is expected end of 2019 which probably won't happen. Like I said, first half 2020 if you're lucky.

If you know its already safe then you must know that it is proven to to be efficaous on patients already as well. Funny a few posts ago you siad that it might fail due to a reaction. Bioteck always so negative and contradictory.....

That news release was from Trout.... they are being more conservative. Funny you spend all your time on this blog putting down Sva.... this sounds personal, not an investment.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features